🔗 Visit the ClinicalTrials.gov page for NCT00248170
| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Randomized phase II neoadjuvant comparison between letrozole, anastrozole, and exemestane for postmenopausal women with estrogen receptor-rich stage 2 to 3 breast cancer: clinical and biomarker outcomes and predictive value of the baseline PAM50-based intrinsic subtype--ACOSOG Z1031. | J Clin Oncol | 2011 | 2.71 |
| 2 | The discovery and mechanism of action of letrozole. | Breast Cancer Res Treat | 2007 | 1.04 |
| 3 | A decade of letrozole: FACE. | Breast Cancer Res Treat | 2007 | 0.90 |
| 4 | Landscape of neoadjuvant therapy for breast cancer. | Ann Surg Oncol | 2015 | 0.85 |
| 5 | Use of neoadjuvant data to design adjuvant endocrine therapy trials for breast cancer. | Nat Rev Clin Oncol | 2012 | 0.85 |
| 6 | Anastrozole Use in Early Stage Breast Cancer of Post-Menopausal Women. | Clin Med Ther | 2009 | 0.82 |